Supplemental Condensed Consolidating Financial Information (Condensed Consolidating Statement Of Cash Flows) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Operating activities
Net income (loss)	$ 2,485	$ (32,906)	$ (26,306)	$ (30,728)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	65,899	85,817	188,882	183,446
Accretion	1,721	6,458	10,645	15,254
Equity compensation	3,035	2,631	8,089	6,814
Deferred income tax expense (benefit)			(57,713)	(28,837)
Amortization of debt discount and issuance costs			10,224	7,441
Contingent consideration		(4,660)		(4,825)
Impairment of long-lived assets	20	219	251	1,180
Other			(1,417)	(1,474)
Changes in operating assets and liabilities:
Accounts receivable			3,489	6,147
Prepaid expenses and other			(8,344)	(11,674)
Accounts payable			(3,839)	10,517
Accrued expenses, deferred revenue, and other liabilities			21,051	(918)
Net cash provided by (used in) operating activities			145,012	152,343
Investing activities
Purchases of property and equipment			(53,830)	(39,175)
Payments for acquisitions, net of cash acquired			1,502	(717,669)
Purchases of technology-based intangible assets			(43,495)	(3,676)
Net cash provided by (used in) investing activities			(95,823)	(760,520)
Financing activities
Proceeds from Term Loan Facility				385,411
Proceeds from Senior Notes				243,453
Payments on Term Loan Facility			(13,890)	(11,870)
Proceeds from Revolving Facility				60,000
Payments on Revolving Facility				(60,000)
Payment of debt assumed from acquisition				(154,469)
Payments of deferred financing obligations			(7,621)	(6,173)
Repurchase of Parent common stock			(1,884)	(4,351)
Capital contribution from Investor Group and management				166,881
Payment of contingent consideration				(5,553)
Other				(2,500)
Net cash provided by (used in) financing activities			(23,395)	610,829
Net increase (decrease) in cash and cash equivalents			25,794	2,652
Cash and cash equivalents at beginning of period			66,655	82,306
Cash and cash equivalents at end of period	92,449	84,958	92,449	84,958
Consolidating Adjustments [Member]
Operating activities
Net income (loss)	(13,956)	(7,126)	(18,322)	(47,865)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Equity in earnings of consolidated subsidiaries	13,956	7,126	18,322	47,865
Investing activities
Investment in subsidiaries, net			2,930	(1,019)
Net cash provided by (used in) investing activities			2,930	(1,019)
Financing activities
Distributions from (to) Change Healthcare Holdings, Inc., net			(2,930)	1,019
Net cash provided by (used in) financing activities			(2,930)	1,019
Change Healthcare Holdings, Inc. [Member]
Operating activities
Net income (loss)	2,485	(32,906)	(26,306)	(30,728)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	301	33,133	903	37,633
Accretion	1,721	6,458	10,645	15,254
Equity compensation			286	229
Deferred income tax expense (benefit)			(36,793)	(26,160)
Amortization of debt discount and issuance costs			3,250	2,353
Equity in earnings of consolidated subsidiaries	(13,956)	(7,126)	(18,322)	(47,865)
Other			(1,497)	(1,488)
Changes in operating assets and liabilities:
Prepaid expenses and other			(323)	(30,546)
Accounts payable			284
Accrued expenses, deferred revenue, and other liabilities			12,372	16,627
Due to/from affiliates			60,648	(347,949)
Net cash provided by (used in) operating activities			5,147	(412,640)
Investing activities
Investment in subsidiaries, net			(2,930)	1,019
Net cash provided by (used in) investing activities			(2,930)	1,019
Financing activities
Proceeds from Term Loan Facility				8,274
Proceeds from Senior Notes				243,453
Payments on Term Loan Facility			(272)	(229)
Repurchase of Parent common stock			(1,884)	(4,351)
Capital contribution from Investor Group and management				166,881
Other				(2,500)
Net cash provided by (used in) financing activities			(2,156)	411,528
Net increase (decrease) in cash and cash equivalents			61	(93)
Cash and cash equivalents at beginning of period			738	796
Cash and cash equivalents at end of period	799	703	799	703
Guarantor Subsidiaries [Member]
Operating activities
Net income (loss)	13,956	7,126	18,322	47,865
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	65,598	52,684	187,979	145,813
Equity compensation			7,803	6,585
Deferred income tax expense (benefit)			(20,920)	(2,677)
Amortization of debt discount and issuance costs			6,974	5,088
Contingent consideration		(4,660)		(4,825)
Impairment of long-lived assets	20	219	251	1,180
Other			80	14
Changes in operating assets and liabilities:
Accounts receivable			3,489	6,147
Prepaid expenses and other			(8,021)	18,872
Accounts payable			(4,123)	10,517
Accrued expenses, deferred revenue, and other liabilities			8,679	(17,545)
Due to/from affiliates			(60,648)	347,949
Net cash provided by (used in) operating activities			139,865	564,983
Investing activities
Purchases of property and equipment			(53,830)	(39,175)
Payments for acquisitions, net of cash acquired			1,502	(717,669)
Purchases of technology-based intangible assets			(43,495)	(3,676)
Net cash provided by (used in) investing activities			(95,823)	(760,520)
Financing activities
Distributions from (to) Change Healthcare Holdings, Inc., net			2,930	(1,019)
Proceeds from Term Loan Facility				377,137
Payments on Term Loan Facility			(13,618)	(11,641)
Proceeds from Revolving Facility				60,000
Payments on Revolving Facility				(60,000)
Payment of debt assumed from acquisition				(154,469)
Payments of deferred financing obligations			(7,621)	(6,173)
Payment of contingent consideration				(5,553)
Net cash provided by (used in) financing activities			(18,309)	198,282
Net increase (decrease) in cash and cash equivalents			25,733	2,745
Cash and cash equivalents at beginning of period			65,917	81,510
Cash and cash equivalents at end of period	$ 91,650	$ 84,255	$ 91,650	$ 84,255